Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. The 5-year survival rate after curative resection is almost 80%, however, it is still less than satisfactory for metastatic CRC (mCRC). The combination approach including surgery, chemotherapy, molecular targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kano, Yoshihito, Suenaga, Mitsukuni, Uetake, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378516/
https://www.ncbi.nlm.nih.gov/pubmed/37504340
http://dx.doi.org/10.3390/curroncol30070480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378516/
https://www.ncbi.nlm.nih.gov/pubmed/37504340
http://dx.doi.org/10.3390/curroncol30070480

Ejemplares similares